Clinical Research White Papers

Explore a library of whitepapers covering industry trends, evolving regional regulations, emerging technologies, and strategic developments shaping the future of drug development. Drawing on global market analysis and real-world experience, Novotech provides these invaluable perspectives to inform your clinical trial planning and execution.

Filter by

Reset filter
July 2, 2025 Whitepaper

2025 Global Report for In-Vivo CAR Cell Therapy

Explore global trends shaping in-vivo CAR therapies—delivery innovations, clinical trial momentum, and regulatory strategies across oncology and autoimmune diseases....

Download
June 12, 2025 Whitepaper

Live Biotherapeutic Products Whitepaper 2025

Live biotherapeutic products (LBPs) are gaining momentum in the drug development space, emphasisin...

Download
March 19, 2025 Whitepaper

Optimizing siRNA Therapeutics: Addressing Nonclinical and Manufacturing Complexities

Recent FDA approvals of siRNA drugs have revolutionized drug development for this therapeutic modality, which leverag...

Download
March 10, 2025 Whitepaper

Stay Ahead of the Curve: Infectious Disease Clinical Trial Trends & Insights for 2025

Discover the latest data and strategic insights shaping the global infectious disease clinical trial landscape....

Download
January 9, 2025 Whitepaper

Oncolytic Virus Therapy Clinical Trials Global Landscape Whitepaper 2024

Download the Comprehensive Guide on Global Oncolytic Virus Therapy Clinical Trials...

Download
November 18, 2024 Whitepaper

Vaccine Clinical Trials Global Landscape Whitepaper 2024

Download the Comprehensive Guide on Global Vaccine Clinical Trials...

Download
September 12, 2024 Whitepaper

Cell and Gene Therapies – Global Clinical Trial Landscape (2024)

Explore the latest Global Developments in Cell and Gene Therapy Clinical Trials....

Download
August 15, 2024 Whitepaper

RNA Therapy Clinical Trials Whitepaper – 2024

Explore the future of RNA therapeutics with Novotech's comprehensive whitepaper....

Download
June 19, 2024 Whitepaper

Radiopharmaceutical Therapy Innovations & Global Clinical Trial Insights 2024

Explore the Latest Innovations, Clinical Trials, and Future Directions in Radiopharmaceuticals...

Download
May 21, 2024 Whitepaper

Comprehensive Report on Antibody-Drug Conjugates Clinical Trials 2024

Download the 2024 clinical trial report on Antibody-Drug Conjugates, covering new drug developments and market insigh...

Download
March 5, 2024 Whitepaper

Precision Oncology Clinical Trials & Statistics 2024

Explore the transformative role of precision oncology in cancer treatment with Novotech CRO's whitepaper....

Download
November 24, 2023 Whitepaper

Immune Checkpoint Inhibitors Global Clinical Trials Landscape (2023)

Explore the latest trends in immune checkpoint inhibitors clinical trials....

Download
October 30, 2023 Whitepaper

Navigating The Biotech Landscape: Insights Into Clinical Trials, Funding Trends, Challenges, And…

Biotech Layoffs 2023: Evolving Landscape & Funding Analysis...

Download
October 19, 2023 Whitepaper

The State of CAR-T Research in China

China has emerged as a global leader in CAR T-cell therapy research, with over half of all CAR-T clinical trials...

Download
September 5, 2023 Whitepaper

Rare Disease – Global Clinical Trial Landscape (2018-2022)

Exploring the Rare Diseases Global Clinical Trials Landscape: Unveiling Challenges, Trends, and Promising Adv...

Download
March 28, 2023 Whitepaper

Navigating the FDA Approval Processes: Capitalize on Regulatory Expertise to Simplify the Complex

While global turbulent conditions in the development market over the past few years have introduced novel forces to t...

Download
March 2, 2023 Whitepaper

Multi-Specific Monoclonal Antibodies – Global Clinical Trial Landscape - Focus On Asia Pacific

Asia Pacific has been the fastest growing region in multi-specific monoclonal antibody trials since 2018, with the re...

Download
February 8, 2023 Whitepaper

Phase I Trials Global Clinical Trial Landscape – Focus On Asia Pacific

Asia Pacific has been the fastest growing region in Phase I trials in the last ten years, reaching a share...

Download
December 16, 2022 Whitepaper

Bispecific Antibodies - CMC Considerations

Bispecific antibodies (bsAbs) are genetically engineered, recombinant antibodies that consist of two distinct bi...

Download
December 13, 2022 Whitepaper

State of the Global Biotech Landscape: Where the Opportunities Lie

Over the last five years, the global biotech and pharmaceutical landscape has witnessed continued growth....

Download
November 8, 2022 Whitepaper

Non-Clinical Testing Considerations: Drugs vs Devices

While drugs and devices differ in their development, clinical trial phases and regulatory guidelines, the most import...

Download
November 8, 2022 Whitepaper

Top Therapeutic Areas APAC-CT LANDSCAPE 2022

The global clinical trial landscape has changed significantly, with the Asia Pacific involved in more than a third of...

Download
October 25, 2022 Whitepaper

The China Biotech Landscape – Opportunities in China and the Path to USFDA Approval

Global biopharma companies are looking to capitalize on value creation across different geographic regions through ut...

Download
September 23, 2022 Whitepaper

Understanding the benefits of the Analytical Target Profile (ATP)

The 2022 revised version of ICH Q14 describes the ATP as a prospective summary of the performance characteristics des...

Download
August 5, 2022 Whitepaper

Immuno-oncology – Asia pacific – clinical Trial landscape

Asia Pacific has shown significant increase in Immuno-oncology trials between 2017 and 2021 and contributes to more than a third...

Download
August 1, 2022 Whitepaper

Modern Technologies Transforming Clinical Development in the APAC Region

Traditional clinical trial models are outdated and causes multiple issues for patients, trial sites, and sponsors....

Download
June 28, 2022 Whitepaper

The role of real world evidence to support US FDA and TGA registrations

Real world evidence (RWE) can contribute valuable information to new medicine registrations, in particular for diseases that are difficult to...

Download
May 26, 2022 Whitepaper

Next Generation Sequencing

NGS profiling improves patient outcomes while also lowering treatment costs and time to diagnosis for cancer patients...

Download
May 26, 2022 Whitepaper

Evolution of Clinical Trials in the Asia Pacific Region Compared to the US and the EU5

Over the last five years, the global clinical trial landscape has changed significantly. During the analysis period between 2017-2021...

Download
August 19, 2021 Whitepaper

Clinical Development Strategies for Western Biotech Companies in China

China’s evolving regulatory reforms have greatly impacted review and approval timelines, streamlined processes, and expedited the development of innovative drugs....

Download
May 26, 2021 Whitepaper

The Benefits of Asia-Pacific Clinical Trials For Biotechs

There has been a continued shift of innovation from big pharma companies to biotechs, with the latter paving the ways...

Download
August 27, 2019 Whitepaper

Asia: Preferred Destination for Clinical Trials

Asia is the fastest-growing medicines market globally, with China currently the world’s second-largest market after the US, with medicines spending...

Download
August 27, 2019 Whitepaper

Australia: Preferred Destination for Early Phase Clinical Trials

The clinical trials process is complex. It requires substantial investment and skilled human re-sources, and involves risks, not least, the...

Download